Search by Practice
Latest Updates / Healthcare Regulatory
November 16, 2022
How to Maintain Patient Privacy when Digitally Transferring Medical Information
The Israeli Privacy Protection Authority has published a document containing a series of recommendations that address the use of ordinary and non-designated applications for sharing information among a variety of parties.
October 2, 2022
Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog
Sagi Gross and Dor Levi-Tam represented Pronto Diagnostics and its owners in a transaction to sell control of the company to Novolog. Pronto operates in the field of molecular genetic diagnostics.
May 22, 2022
BioGenCell Completes USD 16 Million Seed Round
Our firm represents BioGenCell, a stem cell research and development company located at Laniado Hospital. The company recently announced the completion of a USD 16 million seed round investment, aided by counsel from Advs. Itay Gura and Inbar Katzir. Our firm has represented the company since its inception.
January 2, 2019
"High" Companies
The Israel Securities Authority published an announcement to investors with various emphases about public companies operating in the medical cannabis market. Its announcement calls investors’ attention to several parameters they should consider when deciding whether to invest in securities of public companies operating, or expecting to begin operating, in the medical cannabis market.
January 1, 2019
Amendment to Hazardous Drugs Ordinance Promotes Regulation in Cannabis Market
On December 25, 2018, the Israeli parliament approved the second and third readings of an amendment to the Hazardous Drugs Ordinance (Delegation of Supervisory and Enforcement Authorities Relating to Cannabis for Medicinal and Research Purposes).
November 29, 2018
French Tech Tour – Healthcare Delegation
We hosted today a delegation of French startup companies from the life sciences and medtech sectors. The delegation was organized by the Embassy of France and visited Israel to learn about the local life sciences scene. During the event, Adv. Ariella Dreyfuss discussed the Israeli medtech ecosystem and the legal challenges companies should be aware of.